|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$262,397
|
N/A
|
National Institutes of Health
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$600
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$1,187
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$1,995
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$37,927
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Defining driver tumor-suppressors for melanoma using the zebrafish
|
5K99CA201465-02
|
$171,990
|
$171,990
|
ABLAIN, JULIEN
|
BOSTON CHILDREN'S HOSPITAL
|
|
Xeroderma Pigmentosum
|
ZIA CP010187-10777
|
$50,695
|
$10,139
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
1R03CA212798-01
|
$74,250
|
$74,250
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$7,747
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$36,860
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Role of SIRT1 in melanocyte biology and melanocyte transformation
|
5R01CA176748-05
|
$312,288
|
$312,288
|
AHMAD, NIHAL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-02
|
$459,505
|
$459,505
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$54,714
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-02
|
$520,564
|
$260,282
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$48,449
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$899,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
5R01CA169134-05
|
$312,942
|
$156,471
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular mechanisms of BRAF inhibitor induced UPR and autophagy
|
5R01CA198015-03
|
$366,000
|
$366,000
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$75,584
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
|
1R01CA214018-01
|
$456,361
|
$456,361
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$9,108
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$26,513
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-03
|
$42,914
|
$42,914
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$361,715
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapies in mutant BRAF melanoma
|
5R01CA182635-04
|
$321,625
|
$321,625
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Mutant BRAF-regulated transcription factors in melanoma progression
|
5R01CA196278-03
|
$356,850
|
$356,850
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Desmosomal Cadherin Regulation of Pro-inflammatory Cytokine Production in Melanomagenesis
|
3F32CA210498-01S1
|
$711
|
$711
|
ARNETTE, CHRISTOPHER
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$8,750
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$124,000
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$202,962
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$3,750
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$1,800
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$7,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$1,906
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Elucidating the role of CD26 in T cell-mediated tumor immunity
|
5F31CA192787-03
|
$44,044
|
$44,044
|
BAILEY, STEFANIE
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$257,310
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
$99,709
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$43,778
|
Barr, Frederic
|
CCR (NCI)
|
|
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma
|
1F32CA217068-01
|
$56,694
|
$56,694
|
BARROWS, DOUGLAS
|
ROCKEFELLER UNIVERSITY
|
|
Memory potential, molecular characterization, and translational applications of the novel ThEO/TcEO T cell phenotype
|
5F99CA212447-02
|
$37,644
|
$37,644
|
BARTKOWIAK, TODD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
|
1R35CA220481-01
|
$720,975
|
$720,975
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The GNAQ pathway as a therapeutic target in uveal melanoma
|
5R01CA142873-08
|
$306,698
|
$306,698
|
BASTIAN, BORIS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$808,416
|
$40,421
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
$141,173
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S1
|
$249,799
|
$22,482
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S2
|
$123,315
|
$11,098
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S3
|
$46,117
|
$4,151
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-28S4
|
$59,999
|
$5,400
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
Total relevant funding to Melanoma for this search: $153,176,356
|